SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-270277
Filing Date
2020-10-15
Accepted
2020-10-15 16:20:01
Documents
12
Period of Report
2020-10-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d56057d8k.htm   iXBRL 8-K 23612
  Complete submission text file 0001193125-20-270277.txt   144338

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tlry-20201008.xsd EX-101.SCH 2719
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20201008_lab.xml EX-101.LAB 18064
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20201008_pre.xml EX-101.PRE 11263
5 EXTRACTED XBRL INSTANCE DOCUMENT d56057d8k_htm.xml XML 3449
Mailing Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2
Business Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 2064329325
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 201241671
SIC: 2833 Medicinal Chemicals & Botanical Products